메뉴 건너뛰기




Volumn 3, Issue 3, 2010, Pages 98-122

Transcription Factor NF-κb Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Author keywords

Hematologic malignancies; NF b; NF b inhibitors; Proteasome inhibitors; Signal transduction

Indexed keywords

1 [5 HYDROXY 2 (2 THIENYL) 4 QUINAZOLINYLAMINO] 3 METHYL 2,5 PYRROLEDIONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; 6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; ARSENIC TRIOXIDE; AZACITIDINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CAMPTOTHECIN; CARFILZOMIB; CD40 ANTIGEN; DAUNORUBICIN; DEXAMETHASONE; ETODOLAC; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LC 1; LENALIDOMIDE; MITOXANTRONE; MLN 120 B; SDX 101; SDX 308; SMALL INTERFERING RNA; SN 50; TELOMERASE REVERSE TRANSCRIPTASE; THALIDOMIDE; TRIPTOLIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN INHIBITOR;

EID: 78650019223     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211003030098     Document Type: Article
Times cited : (56)

References (274)
  • 1
    • 0022930702 scopus 로고
    • Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism
    • Sen, R.; Baltimore, D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell, 1986, 47, 921-928.
    • (1986) Cell , vol.47 , pp. 921-928
    • Sen, R.1    Baltimore, D.2
  • 2
    • 65549164068 scopus 로고    scopus 로고
    • Roles of NF-κB in health and disease: Mechanisms and therapeutic potential
    • Wong, E.T.; Tergaonkar, V. Roles of NF-κB in health and disease: mechanisms and therapeutic potential. Clin. Sci., 2009, 116, 451-465.
    • (2009) Clin. Sci , vol.116 , pp. 451-465
    • Wong, E.T.1    Tergaonkar, V.2
  • 3
    • 4444376712 scopus 로고    scopus 로고
    • Signaling to NF-κB
    • Hayden, M.S.; Ghosh, S. Signaling to NF-κB. Genes Dev., 2004, 15, 2195-2224.
    • (2004) Genes Dev , vol.15 , pp. 2195-2224
    • Hayden, M.S.1    Ghosh, S.2
  • 4
    • 33750466230 scopus 로고    scopus 로고
    • Introduction to NF-kappa B: Players, pathways, perspectives
    • Gilmore, T.D. Introduction to NF-kappa B: players, pathways, perspectives. Oncogene, 2006, 25, 6680-6684.
    • (2006) Oncogene , vol.25 , pp. 6680-6684
    • Gilmore, T.D.1
  • 5
    • 0036234459 scopus 로고    scopus 로고
    • Missing pieces in the NF-κB puzzle
    • Ghosh, S.; Karin, M. Missing pieces in the NF-κB puzzle. Cell, 2002, 109(Suppl), S81-S96.
    • (2002) Cell , vol.109 , Issue.SUPPL.
    • Ghosh, S.1    Karin, M.2
  • 6
    • 38849199203 scopus 로고    scopus 로고
    • Shared principles in NF-kappa B signaling
    • Hayden, M.S.; Ghosh, S. Shared principles in NF-kappa B signaling. Cell, 2008, 132, 344-362.
    • (2008) Cell , vol.132 , pp. 344-362
    • Hayden, M.S.1    Ghosh, S.2
  • 7
    • 33750467991 scopus 로고    scopus 로고
    • Unravelling the complexities of the NFkappaB signalling pathway using mouse knockout and transgenic models
    • Gerondakis, S.; Grumont, R.; Gugasyan, R.; Wong, L.; Isomura, I.; Ho, W.; Banerjee, V. Unravelling the complexities of the NFkappaB signalling pathway using mouse knockout and transgenic models. Oncogene, 2006, 25, 6781-6799.
    • (2006) Oncogene , vol.25 , pp. 6781-6799
    • Gerondakis, S.1    Grumont, R.2    Gugasyan, R.3    Wong, L.4    Isomura, I.5    Ho, W.6    Banerjee, V.7
  • 9
    • 0023853764 scopus 로고
    • V-rel Oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells
    • Gilmore, T.D.; Temin, H.M. v-rel Oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J. Virol., 1988, 62, 703-714.
    • (1988) J. Virol , vol.62 , pp. 703-714
    • Gilmore, T.D.1    Temin, H.M.2
  • 13
    • 36348988506 scopus 로고    scopus 로고
    • Nuclear factor kB as a target for new drug development in myeloid malignancies
    • Cilloni, D.; Martinelli, G.; Messa, F.; Baccarani, M.; Saglio, G. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica, 2007, 92, 1224-1229.
    • (2007) Haematologica , vol.92 , pp. 1224-1229
    • Cilloni, D.1    Martinelli, G.2    Messa, F.3    Baccarani, M.4    Saglio, G.5
  • 14
    • 70349289739 scopus 로고    scopus 로고
    • Nuclear factor-kappaB signaling: A contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia
    • Reikvam, H.; Olsnes, A.M.; Gjertsen, B.T.; Ersvar, E.; Bruserud, O. Nuclear factor-kappaB signaling: A contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia. Crit. Rev. Oncog., 2009, 15, 1-41.
    • (2009) Crit. Rev. Oncog , vol.15 , pp. 1-41
    • Reikvam, H.1    Olsnes, A.M.2    Gjertsen, B.T.3    Ersvar, E.4    Bruserud, O.5
  • 15
    • 55949105242 scopus 로고    scopus 로고
    • Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia
    • Jenkins, C.; Hewamana, S.; Gilkes, A.; Neelakantan, S.; Crooks, P.; Mills, K.; Pepper, C.; Burnett, A. Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia. Br. J. Haematol., 2008, 143, 661-671.
    • (2008) Br. J. Haematol , vol.143 , pp. 661-671
    • Jenkins, C.1    Hewamana, S.2    Gilkes, A.3    Neelakantan, S.4    Crooks, P.5    Mills, K.6    Pepper, C.7    Burnett, A.8
  • 16
    • 0037111664 scopus 로고    scopus 로고
    • Tumor necrosis factor receptorassociated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: Analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis
    • Munzert, G.; Kirchner, D.; Stobbe, H.; Bergmann, L.; Schmid, R.M.; Döhner, H.; Heimpel, H. Tumor necrosis factor receptorassociated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood, 2002, 100, 3749-3756.
    • (2002) Blood , vol.100 , pp. 3749-3756
    • Munzert, G.1    Kirchner, D.2    Stobbe, H.3    Bergmann, L.4    Schmid, R.M.5    Döhner, H.6    Heimpel, H.7
  • 17
    • 2342641470 scopus 로고    scopus 로고
    • Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Leuk
    • Munzert, G.; Kirchner, D.; Ottmann, O.; Bergmann, L.; Schmid, R.M. Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Leuk. Lymphoma, 2004, 45, 1181-1184.
    • (2004) Lymphoma , vol.45 , pp. 1181-1184
    • Munzert, G.1    Kirchner, D.2    Ottmann, O.3    Bergmann, L.4    Schmid, R.M.5
  • 19
    • 33749260717 scopus 로고    scopus 로고
    • Deregulated NFkappaB activity in haematological malignancies
    • Keutgens, A.; Robert, I.; Viatour, P.; Chariot, A. Deregulated NFkappaB activity in haematological malignancies. Biochem. Pharmacol., 2006, 72, 1069-1080.
    • (2006) Biochem. Pharmacol , vol.72 , pp. 1069-1080
    • Keutgens, A.1    Robert, I.2    Viatour, P.3    Chariot, A.4
  • 20
    • 58149355768 scopus 로고    scopus 로고
    • The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
    • Hewamana, S.; Lin, T.T.; Jenkins, C.; Burnett, A.K.; Jordan, C.T.; Fegan, C.; Brennan, P.; Rowntree, C.; Pepper, C. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. Clin. Cancer Res., 2008, 14, 8102-8111.
    • (2008) Clin. Cancer Res , vol.14 , pp. 8102-8111
    • Hewamana, S.1    Lin, T.T.2    Jenkins, C.3    Burnett, A.K.4    Jordan, C.T.5    Fegan, C.6    Brennan, P.7    Rowntree, C.8    Pepper, C.9
  • 21
    • 0742324492 scopus 로고    scopus 로고
    • NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors
    • Turco, M.C.; Romano, M.F.; Petrella, A.; Bisogni, R.; Tassone, P.; Venuta, S. NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia, 2004, 18, 11-17.
    • (2004) Leukemia , vol.18 , pp. 11-17
    • Turco, M.C.1    Romano, M.F.2    Petrella, A.3    Bisogni, R.4    Tassone, P.5    Venuta, S.6
  • 23
    • 51249095557 scopus 로고    scopus 로고
    • The role of NF-κB in lymphoid malignancies
    • Packham, G. The role of NF-κB in lymphoid malignancies. Br. J. Haematol., 2008, 143, 3-15.
    • (2008) Br. J. Haematol , vol.143 , pp. 3-15
    • Packham, G.1
  • 24
    • 33947586159 scopus 로고    scopus 로고
    • Aberrant NF-kappaB signaling in lymphoma: Mechanisms, consequences, and therapeutic implications
    • Jost, P.J.; Ruland, J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood, 2007, 109, 2700-2707.
    • (2007) Blood , vol.109 , pp. 2700-2707
    • Jost, P.J.1    Ruland, J.2
  • 25
    • 70249122331 scopus 로고    scopus 로고
    • Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFκB activity in follicular lymphoma
    • Green, M.R.; Gandhi, M.K.; Courtney, M.J.; Marlton, P.; Griffiths, L. Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFκB activity in follicular lymphoma. Leuk. Res., 2009, 33, 1699-1702.
    • (2009) Leuk. Res , vol.33 , pp. 1699-1702
    • Green, M.R.1    Gandhi, M.K.2    Courtney, M.J.3    Marlton, P.4    Griffiths, L.5
  • 26
    • 0035725855 scopus 로고    scopus 로고
    • Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: Downregulation of NF-kappa B induces apoptosis
    • Ni, H.; Ergin, M.; Huang, Q.; Qin, J.Z.; Amin, H.M.; Martinez, R.L.; Saeed, S.; Barton, K.; Alkan, S. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br. J. Haematol., 2001, 115, 279-286.
    • (2001) Br. J. Haematol , vol.115 , pp. 279-286
    • Ni, H.1    Ergin, M.2    Huang, Q.3    Qin, J.Z.4    Amin, H.M.5    Martinez, R.L.6    Saeed, S.7    Barton, K.8    Alkan, S.9
  • 27
    • 0035207110 scopus 로고    scopus 로고
    • The role of nuclear factorkappaB in the biology and treatment of multiple myeloma
    • Berenson, J.R.; Ma, H.M.; Vescio, R. The role of nuclear factorkappaB in the biology and treatment of multiple myeloma. Semin. Oncol., 2001, 28, 626-633.
    • (2001) Semin. Oncol , vol.28 , pp. 626-633
    • Berenson, J.R.1    Ma, H.M.2    Vescio, R.3
  • 28
    • 14644413996 scopus 로고    scopus 로고
    • Regulation of NF-κB in multiple myeloma: Therapeutic implications
    • Feinman, R.; Siegel, D.S.; Berenson, J. Regulation of NF-κB in multiple myeloma: therapeutic implications. Clin. Adv. Hematol. Oncol., 2004, 2, 162-166.
    • (2004) Clin. Adv. Hematol. Oncol , vol.2 , pp. 162-166
    • Feinman, R.1    Siegel, D.S.2    Berenson, J.3
  • 29
    • 1842579486 scopus 로고    scopus 로고
    • Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
    • Bharti, A.C.; Shishodia, S.; Reuben, J.M.; Weber, D.; Alexanian, R.; Raj-Vadhan, S.; Estrov, Z.; Talpaz, M.; Aggarwal, B.B. Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood, 2004, 103, 3175-3184.
    • (2004) Blood , vol.103 , pp. 3175-3184
    • Bharti, A.C.1    Shishodia, S.2    Reuben, J.M.3    Weber, D.4    Alexanian, R.5    Raj-Vadhan, S.6    Estrov, Z.7    Talpaz, M.8    Aggarwal, B.B.9
  • 30
    • 35548984453 scopus 로고    scopus 로고
    • SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma
    • Lentzsch, S.; Elliott, G.; Roodman, G.D. SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma. Arch. Pharm. (Weinheim), 2007, 340, 511-516.
    • (2007) Arch. Pharm. (Weinheim) , vol.340 , pp. 511-516
    • Lentzsch, S.1    Elliott, G.2    Roodman, G.D.3
  • 33
    • 0033596121 scopus 로고    scopus 로고
    • Activators and target genes of Rel/NF-kappaB transcription factors
    • Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 1999, 18, 6853-6866.
    • (1999) Oncogene , vol.18 , pp. 6853-6866
    • Pahl, H.L.1
  • 35
    • 77349094234 scopus 로고    scopus 로고
    • Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma
    • Xie, T.X.; Xia, Z.; Zhang, N.; Gong, W.; Huang, S. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol. Rep., 2010, 23, 725-732.
    • (2010) Oncol. Rep , vol.23 , pp. 725-732
    • Xie, T.X.1    Xia, Z.2    Zhang, N.3    Gong, W.4    Huang, S.5
  • 36
    • 77952941515 scopus 로고    scopus 로고
    • Sesamin manifests chemopreventive effects through the suppression of NF-kappaB-regulated cell survival, proliferation, invasion, and angiogenic gene products
    • Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Pandey, M.P.; Joy, B.; Guha, S.; Krishnan, S.; Aggarwal, B.B. Sesamin manifests chemopreventive effects through the suppression of NF-kappaB-regulated cell survival, proliferation, invasion, and angiogenic gene products. Mol. Cancer Res., 2010, 8, 751-761.
    • (2010) Mol. Cancer Res , vol.8 , pp. 751-761
    • Harikumar, K.B.1    Sung, B.2    Tharakan, S.T.3    Pandey, M.P.4    Joy, B.5    Guha, S.6    Krishnan, S.7    Aggarwal, B.B.8
  • 37
    • 0037675869 scopus 로고    scopus 로고
    • NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants
    • Takebayashi, T.; Higashi, H.; Sudo, H.; Ozawa, H.; Suzuki, E.; Shirado, O.; Katoh, H.; Hatakeyama, M. NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants. J. Biol. Chem., 2003, 278, 14897-14905.
    • (2003) J. Biol. Chem , vol.278 , pp. 14897-14905
    • Takebayashi, T.1    Higashi, H.2    Sudo, H.3    Ozawa, H.4    Suzuki, E.5    Shirado, O.6    Katoh, H.7    Hatakeyama, M.8
  • 38
    • 0028903216 scopus 로고
    • Members of the nuclear factor kappa B family transactivate the murine c-myb gene
    • Toth, C.R.; Hostutler, R.F.; Baldwin, A.S. Jr.; Bender, T.P. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J. Biol. Chem., 1995, 270, 7661-7671.
    • (1995) J. Biol. Chem , vol.270 , pp. 7661-7671
    • Toth, C.R.1    Hostutler, R.F.2    Baldwin Jr., A.S.3    Bender, T.P.4
  • 40
    • 0036009115 scopus 로고    scopus 로고
    • NF-kappaB at the crossroads of life and death
    • Karin, M.; Lin, A. NF-kappaB at the crossroads of life and death. Nat. Immunol., 2002, 3, 221-227.
    • (2002) Nat. Immunol , vol.3 , pp. 221-227
    • Karin, M.1    Lin, A.2
  • 43
    • 0033596124 scopus 로고    scopus 로고
    • Aberrant rel/nfkb genes and activity in human cancer
    • Rayet, B.; Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 1999, 18, 6938-6947.
    • (1999) Oncogene , vol.18 , pp. 6938-6947
    • Rayet, B.1    Gelinas, C.2
  • 44
    • 0035950554 scopus 로고    scopus 로고
    • Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
    • Gilmore, T.D.; Cormier, C.; Jean-Jacques, J.; Gapuzan, M.E. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene, 2001, 20, 7098-7103.
    • (2001) Oncogene , vol.20 , pp. 7098-7103
    • Gilmore, T.D.1    Cormier, C.2    Jean-Jacques, J.3    Gapuzan, M.E.4
  • 45
    • 1842432464 scopus 로고    scopus 로고
    • The c-Rel transcription factor and B-cell proliferation: A deal with the devil
    • Gilmore, T.D.; Kalaitzidis, D.; Liang, M.C.; Starczynowski, D.T. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene, 2004, 23, 2275-2286.
    • (2004) Oncogene , vol.23 , pp. 2275-2286
    • Gilmore, T.D.1    Kalaitzidis, D.2    Liang, M.C.3    Starczynowski, D.T.4
  • 46
    • 0033596128 scopus 로고    scopus 로고
    • Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
    • Gilmore, T.D. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene, 1999, 22, 6925-6937.
    • (1999) Oncogene , vol.22 , pp. 6925-6937
    • Gilmore, T.D.1
  • 47
    • 0028804551 scopus 로고
    • Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses
    • Sha, W.C.; Liou, H.C.; Tuomanen, E.I.; Baltimore, D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell, 1995, 80, 321-330.
    • (1995) Cell , vol.80 , pp. 321-330
    • Sha, W.C.1    Liou, H.C.2    Tuomanen, E.I.3    Baltimore, D.4
  • 48
    • 0029150389 scopus 로고
    • Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
    • Köntgen, F.; Grumont, R.J.; Strasser, A.; Metcalf, D.; Li, R.; Tarlinton, D.; Gerondakis, S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev., 1995, 9, 1965-1977.
    • (1995) Genes Dev , vol.9 , pp. 1965-1977
    • Köntgen, F.1    Grumont, R.J.2    Strasser, A.3    Metcalf, D.4    Li, R.5    Tarlinton, D.6    Gerondakis, S.7
  • 50
    • 0032568792 scopus 로고    scopus 로고
    • Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation
    • Yamaoka, S.; Courtois, G.; Bessia, C.; Whiteside, S.T.; Weil, R.; Agou, F.; Kirk, H.E.; Kay, R.J.; Israël, A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell, 1998, 93, 1231-1240.
    • (1998) Cell , vol.93 , pp. 1231-1240
    • Yamaoka, S.1    Courtois, G.2    Bessia, C.3    Whiteside, S.T.4    Weil, R.5    Agou, F.6    Kirk, H.E.7    Kay, R.J.8    Israël, A.9
  • 51
    • 0032541657 scopus 로고    scopus 로고
    • IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex
    • Rothwarf, D.M.; Zandi, E.; Natoli, G.; Karin, M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature, 1998, 395, 297-300.
    • (1998) Nature , vol.395 , pp. 297-300
    • Rothwarf, D.M.1    Zandi, E.2    Natoli, G.3    Karin, M.4
  • 53
    • 61849127839 scopus 로고    scopus 로고
    • The IkappaB kinase complex: Master regulator of NF-kappaB signaling
    • Solt, L.A.; May, M.J. The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol. Res., 2008, 42, 3-18.
    • (2008) Immunol. Res , vol.42 , pp. 3-18
    • Solt, L.A.1    May, M.J.2
  • 54
    • 70350442569 scopus 로고    scopus 로고
    • NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation
    • Solt, L.A.; Madge, L.A.; May, M.J. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation. J. Biol. Chem., 2009, 284, 27596-27608.
    • (2009) J. Biol. Chem , vol.284 , pp. 27596-27608
    • Solt, L.A.1    Madge, L.A.2    May, M.J.3
  • 56
    • 0033106149 scopus 로고    scopus 로고
    • A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways
    • Maniatis, T. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev., 1999, 13, 505-510.
    • (1999) Genes Dev , vol.13 , pp. 505-510
    • Maniatis, T.1
  • 57
    • 0034084163 scopus 로고    scopus 로고
    • Phosphorylation meets ubiquitination: The control of NFκB activity
    • Karin, M.; Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NFκB activity. Annu. Rev. Immunol., 2000, 18, 621-663.
    • (2000) Annu. Rev. Immunol , vol.18 , pp. 621-663
    • Karin, M.1    Ben-Neriah, Y.2
  • 58
    • 33645703930 scopus 로고    scopus 로고
    • Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
    • Wu, C.J.; Conze, D.B.; Li, T.; Srinivasula, S.M.; Ashwell, J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell. Biol., 2006, 8, 398-406.
    • (2006) Nat. Cell. Biol , vol.8 , pp. 398-406
    • Wu, C.J.1    Conze, D.B.2    Li, T.3    Srinivasula, S.M.4    Ashwell, J.D.5
  • 59
    • 38049028109 scopus 로고    scopus 로고
    • Phosphorylation of serine 68 in the IκB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-κB activity
    • Palkowitsch, L.; Leidner, J.; Ghosh, S.; Marienfeld, R.B. Phosphorylation of serine 68 in the IκB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-κB activity. J. Biol. Chem., 2008, 283, 76-86.
    • (2008) J. Biol. Chem , vol.283 , pp. 76-86
    • Palkowitsch, L.1    Leidner, J.2    Ghosh, S.3    Marienfeld, R.B.4
  • 60
    • 33645271646 scopus 로고    scopus 로고
    • Advances in NF-κB signaling transduction and transcription. Cell. Mol
    • Xiao, W. Advances in NF-κB signaling transduction and transcription. Cell. Mol. Immunol., 2004, 1, 425-435.
    • (2004) Immunol , vol.1 , pp. 425-435
    • Xiao, W.1
  • 61
    • 24944489952 scopus 로고    scopus 로고
    • Stimulus specificity of gene expression programs determined by temporal control of IKK activity
    • Werner, S.L.; Barken, D.; Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science, 2005, 309, 1857-1861.
    • (2005) Science , vol.309 , pp. 1857-1861
    • Werner, S.L.1    Barken, D.2    Hoffmann, A.3
  • 62
    • 24944554790 scopus 로고    scopus 로고
    • Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis: CREB and NF-κB as key regulators
    • Park, J.M.; Greten, F.R.; Wong, A.; Westrick, R.J.; Arthur, J.S.; Otsu, K.; Hoffmann, A.; Montminy, M.; Karin, M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis: CREB and NF-κB as key regulators. Immunity, 2005, 23, 319-329.
    • (2005) Immunity , vol.23 , pp. 319-329
    • Park, J.M.1    Greten, F.R.2    Wong, A.3    Westrick, R.J.4    Arthur, J.S.5    Otsu, K.6    Hoffmann, A.7    Montminy, M.8    Karin, M.9
  • 63
    • 24944586285 scopus 로고    scopus 로고
    • Achieving stability of lipopolysaccharide-induced NF-kappaB activation
    • Covert, M.W.; Leung, T.H.; Gaston, J.E.; Baltimore, D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science, 2005, 309, 1854-1857.
    • (2005) Science , vol.309 , pp. 1854-1857
    • Covert, M.W.1    Leung, T.H.2    Gaston, J.E.3    Baltimore, D.4
  • 64
    • 33750448661 scopus 로고    scopus 로고
    • Transcriptional regulation via the NF-κB signaling module
    • Hoffmann, A.; Natoli, G.; Ghosh, G. Transcriptional regulation via the NF-κB signaling module. Oncogene, 2006, 25, 6706-6716.
    • (2006) Oncogene , vol.25 , pp. 6706-6716
    • Hoffmann, A.1    Natoli, G.2    Ghosh, G.3
  • 65
    • 33645936634 scopus 로고    scopus 로고
    • Regulation of NF-κB transcriptional activity
    • Vermeulen, L.; Vanden Berghe, W.; Haegeman, G. Regulation of NF-κB transcriptional activity. Cancer Treat. Res., 2006, 130, 89-102.
    • (2006) Cancer Treat. Res , vol.130 , pp. 89-102
    • Vermeulen, L.1    Vanden, B.W.2    Haegeman, G.3
  • 67
    • 59449108567 scopus 로고    scopus 로고
    • The roles of the classical and alternative nuclear factor-κB pathways: Potential implications for autoimmunity and rheumatoid arthritis
    • Brown, K.D.; Claudio, E.; Siebenlist, U. The roles of the classical and alternative nuclear factor-κB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis. Res. Ther., 2008, 10, 212.
    • (2008) Arthritis. Res. Ther , vol.10 , pp. 212
    • Brown, K.D.1    Claudio, E.2    Siebenlist, U.3
  • 68
    • 35648958721 scopus 로고    scopus 로고
    • IκB kinase-β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NFκB pathway
    • Hutti, J.E.; Turk, B.E.; Asara, J.M.; Ma, A.; Cantley, L.C.; Abbott, D.W. IκB kinase-β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NFκB pathway. Mol. Cell. Biol., 2007, 27, 7451-7461.
    • (2007) Mol. Cell. Biol , vol.27 , pp. 7451-7461
    • Hutti, J.E.1    Turk, B.E.2    Asara, J.M.3    Ma, A.4    Cantley, L.C.5    Abbott, D.W.6
  • 69
    • 77649230307 scopus 로고    scopus 로고
    • Turning off inflammation signaling
    • Sriskantharajah, S.; Ley, S.C. Turning off inflammation signaling. Science, 2010, 327, 1093-1094.
    • (2010) Science , vol.327 , pp. 1093-1094
    • Sriskantharajah, S.1    Ley, S.C.2
  • 70
    • 77649225756 scopus 로고    scopus 로고
    • Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes
    • Shembade, N.; Ma, A.; Harhaj, E.W. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science, 2010, 327, 1135-1139.
    • (2010) Science , vol.327 , pp. 1135-1139
    • Shembade, N.1    Ma, A.2    Harhaj, E.W.3
  • 71
    • 0036771765 scopus 로고    scopus 로고
    • Two pathways to NF-kappaB
    • Pomerantz, J.L.; Baltimore, D. Two pathways to NF-kappaB. Mol. Cell, 2002, 10, 693-695.
    • (2002) Mol. Cell , vol.10 , pp. 693-695
    • Pomerantz, J.L.1    Baltimore, D.2
  • 74
    • 2342464085 scopus 로고    scopus 로고
    • The two NF-kappaB activation pathways and their role in innate and adaptive immunity
    • Bonizzi, G.; Karin, M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol., 2004, 25, 280-288.
    • (2004) Trends Immunol , vol.25 , pp. 280-288
    • Bonizzi, G.1    Karin, M.2
  • 75
    • 0242298578 scopus 로고    scopus 로고
    • CK2 Is a CTerminal IκB Kinase Responsible for NF-κB Activation during the UV Response
    • Kato, T. Jr.; Delhase, M.; Hoffmann, A.; Karin, M. CK2 Is a CTerminal IκB Kinase Responsible for NF-κB Activation during the UV Response. Mol. Cell, 2003, 12, 829-839.
    • (2003) Mol. Cell , vol.12 , pp. 829-839
    • Kato Jr., T.1    Delhase, M.2    Hoffmann, A.3    Karin, M.4
  • 76
    • 45149090556 scopus 로고    scopus 로고
    • Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation
    • Natoli, G.; Chiocca, S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation. Sci. Signal., 2008, 8, pe1.
    • (2008) Sci. Signal , vol.8 , pp. 1
    • Natoli, G.1    Chiocca, S.2
  • 77
    • 54449087372 scopus 로고    scopus 로고
    • Economic and clinical impact of multiple myeloma to managed care
    • Cook, R. Economic and clinical impact of multiple myeloma to managed care. J. Manag. Care Pharm., 2008, 14(Suppl. 7), S19-S25.
    • (2008) J. Manag. Care Pharm , vol.14 , Issue.7
    • Cook, R.1
  • 79
    • 0024541563 scopus 로고
    • The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction
    • Paulie, S.; Rosen, A.; Ehlin-Henriksson, B.; Braesch-Andersen, S.; Jakobson, E.; Koho, H.; Perlmann, P. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J. Immunol., 1989, 142, 590-595.
    • (1989) J. Immunol , vol.142 , pp. 590-595
    • Paulie, S.1    Rosen, A.2    Ehlin-Henriksson, B.3    Braesch-Andersen, S.4    Jakobson, E.5    Koho, H.6    Perlmann, P.7
  • 80
    • 0023108060 scopus 로고
    • Augmentation of normal and malignant B-cell proliferation by monoclonal antibody to the B-cell-specific antigen BP50 (CDW40)
    • Ledbetter, J.A.; Shu, G.; Gallagher, M.; Clark, E.A. Augmentation of normal and malignant B-cell proliferation by monoclonal antibody to the B-cell-specific antigen BP50 (CDW40). J. Immunol., 1987, 138, 788-794.
    • (1987) J. Immunol , vol.138 , pp. 788-794
    • Ledbetter, J.A.1    Shu, G.2    Gallagher, M.3    Clark, E.A.4
  • 81
    • 0042591416 scopus 로고    scopus 로고
    • Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
    • Nowak, A.K.; Robinson, B.W.; Lake, R.A. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res., 2003, 63, 4490-4496.
    • (2003) Cancer Res , vol.63 , pp. 4490-4496
    • Nowak, A.K.1    Robinson, B.W.2    Lake, R.A.3
  • 84
    • 33645060195 scopus 로고    scopus 로고
    • Transfection and ligation of CD40 in human oral keratinocytes affect proliferation, adhesion and migration but not apoptosis in vitro
    • Villarroel Dorrego, M.; Whawell, S.A.; Speight, P.M.; Barrett, A.W. Transfection and ligation of CD40 in human oral keratinocytes affect proliferation, adhesion and migration but not apoptosis in vitro. Clin. Exp. Dermatol., 2006, 31, 266-271.
    • (2006) Clin. Exp. Dermatol , vol.31 , pp. 266-271
    • Villarroel, D.M.1    Whawell, S.A.2    Speight, P.M.3    Barrett, A.W.4
  • 85
    • 34447637912 scopus 로고    scopus 로고
    • The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction
    • Pinzon-Charry, A.; Schmidt, C.W.; Lopez, J.A. The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction. Breast Cancer Res., 2006, 8, 402.
    • (2006) Breast Cancer Res , vol.8 , pp. 402
    • Pinzon-Charry, A.1    Schmidt, C.W.2    Lopez, J.A.3
  • 86
    • 16544387516 scopus 로고    scopus 로고
    • Determinations of B cell fate in immunity and autoimmunity
    • Noelle, R.J.; Erickson, L.D. Determinations of B cell fate in immunity and autoimmunity. Curr. Dis. Autoimmun., 2005, 8, 1-24.
    • (2005) Curr. Dis. Autoimmun , vol.8 , pp. 1-24
    • Noelle, R.J.1    Erickson, L.D.2
  • 87
    • 33749472033 scopus 로고    scopus 로고
    • Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy
    • Koppold, B.; Sauer, G.; Buening, H.; Hallek, M.; Kreienberg, R.; Deissler, H.; Kurzeder, C. Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy. J. Cancer Res. Clin. Oncol., 2006, 132, 787-794.
    • (2006) J. Cancer Res. Clin. Oncol , vol.132 , pp. 787-794
    • Koppold, B.1    Sauer, G.2    Buening, H.3    Hallek, M.4    Kreienberg, R.5    Deissler, H.6    Kurzeder, C.7
  • 88
    • 34248153303 scopus 로고    scopus 로고
    • Expression of CD40 and CD40L on tumor cells: The role of their interaction and new approach to immunotherapy
    • Bereznaya, N.M.; Chekhun, V.F. Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy. Exp. Oncol., 2007, 29, 2-12.
    • (2007) Exp. Oncol , vol.29 , pp. 2-12
    • Bereznaya, N.M.1    Chekhun, V.F.2
  • 90
    • 14544286868 scopus 로고    scopus 로고
    • TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs
    • Hauer, J.; Püschner, S.; Ramakrishnan, P.; Simon, U.; Bongers, M.; Federle, C.; Engelmann, H. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA, 2005, 102, 2874-2879.
    • (2005) Proc. Natl. Acad. Sci. USA , vol.102 , pp. 2874-2879
    • Hauer, J.1    Püschner, S.2    Ramakrishnan, P.3    Simon, U.4    Bongers, M.5    Federle, C.6    Engelmann, H.7
  • 91
    • 33750208645 scopus 로고    scopus 로고
    • Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis
    • Chen, H.; Li, M.; Campbell, R.A.; Burkhardt, K.; Zhu, D.; Li, S.G.; Lee, H.J.; Wang, C.; Zeng, Z.; Gordon, M.S.; Bonavida, B.; Berenson, J.R. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis. Oncogene, 2006, 25, 6520-6527.
    • (2006) Oncogene , vol.25 , pp. 6520-6527
    • Chen, H.1    Li, M.2    Campbell, R.A.3    Burkhardt, K.4    Zhu, D.5    Li, S.G.6    Lee, H.J.7    Wang, C.8    Zeng, Z.9    Gordon, M.S.10    Bonavida, B.11    Berenson, J.R.12
  • 92
    • 2942731516 scopus 로고    scopus 로고
    • Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptorassociated factor 3-induced degradation
    • Liao, G.; Zhang, M.; Harhaj, E.W.; Sun, S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptorassociated factor 3-induced degradation. J. Biol. Chem., 2004, 279, 26243-26250.
    • (2004) J. Biol. Chem , vol.279 , pp. 26243-26250
    • Liao, G.1    Zhang, M.2    Harhaj, E.W.3    Sun, S.C.4
  • 94
    • 0035896422 scopus 로고    scopus 로고
    • Defective lymphotoxin-beta receptorinduced NF-kappaB transcriptional activity in NIK-deficient mice
    • Yin, L.; Wu, L.; Wesche, H.; Arthur, C.D.; White, J.M.; Goeddel, D.V.; Schreiber, R.D. Defective lymphotoxin-beta receptorinduced NF-kappaB transcriptional activity in NIK-deficient mice. Science, 2001, 291, 2162-2165.
    • (2001) Science , vol.291 , pp. 2162-2165
    • Yin, L.1    Wu, L.2    Wesche, H.3    Arthur, C.D.4    White, J.M.5    Goeddel, D.V.6    Schreiber, R.D.7
  • 95
    • 0036794398 scopus 로고    scopus 로고
    • BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells
    • Claudio, E.; Brown, K.; Park, S.; Wang, H.; Siebenlist, U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol., 2002, 3, 958-965.
    • (2002) Nat. Immunol , vol.3 , pp. 958-965
    • Claudio, E.1    Brown, K.2    Park, S.3    Wang, H.4    Siebenlist, U.5
  • 97
    • 5644302162 scopus 로고    scopus 로고
    • Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase
    • Ramakrishnan, P.; Wang, W.; Wallach, D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity, 2004, 21, 477-489.
    • (2004) Immunity , vol.21 , pp. 477-489
    • Ramakrishnan, P.1    Wang, W.2    Wallach, D.3
  • 98
    • 0030611595 scopus 로고    scopus 로고
    • IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
    • Woronicz, J.D.; Gao, X.; Cao, Z.; Rothe, M.; Goeddel, D.V. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science, 1997, 278, 866-869.
    • (1997) Science , vol.278 , pp. 866-869
    • Woronicz, J.D.1    Gao, X.2    Cao, Z.3    Rothe, M.4    Goeddel, D.V.5
  • 99
    • 0033621618 scopus 로고    scopus 로고
    • Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions
    • O'Mahony, A.; Lin, X.; Geleziunas, R.; Greene, W.C. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions. Mol. Cell. Biol., 2000, 20, 1170-1178.
    • (2000) Mol. Cell. Biol , vol.20 , pp. 1170-1178
    • O'Mahony, A.1    Lin, X.2    Geleziunas, R.3    Greene, W.C.4
  • 100
    • 0042467554 scopus 로고    scopus 로고
    • Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB
    • Brummelkamp, T.R.; Nijman, S.M.; Dirac, A.M.; Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature, 2003, 424, 797-801.
    • (2003) Nature , vol.424 , pp. 797-801
    • Brummelkamp, T.R.1    Nijman, S.M.2    Dirac, A.M.3    Bernards, R.4
  • 101
    • 0041967054 scopus 로고    scopus 로고
    • The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination
    • Kovalenko, A.; Chable-Bessia, C.; Cantarella, G.; Israël, A.; Wallach, D.; Courtois, G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature, 2003, 424, 801-805.
    • (2003) Nature , vol.424 , pp. 801-805
    • Kovalenko, A.1    Chable-Bessia, C.2    Cantarella, G.3    Israël, A.4    Wallach, D.5    Courtois, G.6
  • 102
    • 0346333095 scopus 로고    scopus 로고
    • The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor
    • Regamey, A.; Hohl, D.; Liu, J.W.; Roger, T.; Kogerman, P.; Toftgard, R.; Huber, M. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J. Exp. Med., 2003, 198, 1959-1964.
    • (2003) J. Exp. Med , vol.198 , pp. 1959-1964
    • Regamey, A.1    Hohl, D.2    Liu, J.W.3    Roger, T.4    Kogerman, P.5    Toftgard, R.6    Huber, M.7
  • 103
    • 0042467558 scopus 로고    scopus 로고
    • CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members
    • Trompouki, E.; Hatzivassiliou, E.; Tsichritzis, T.; Farmer, H.; Ashworth, A.; Mosialos, G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature, 2003, 424, 793-796.
    • (2003) Nature , vol.424 , pp. 793-796
    • Trompouki, E.1    Hatzivassiliou, E.2    Tsichritzis, T.3    Farmer, H.4    Ashworth, A.5    Mosialos, G.6
  • 104
    • 33646531810 scopus 로고    scopus 로고
    • Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling
    • Massoumi, R.; Chmielarska, K.; Hennecke, K.; Pfeifer, A.; Fässler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell, 2006, 125, 665-677.
    • (2006) Cell , vol.125 , pp. 665-677
    • Massoumi, R.1    Chmielarska, K.2    Hennecke, K.3    Pfeifer, A.4    Fässler, R.5
  • 105
    • 0029595282 scopus 로고
    • The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
    • Rothe, M.; Pan, M.G.; Henzel, W.J.; Ayres, T.M.; Goeddel, D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell, 1995, 83, 1243-1252.
    • (1995) Cell , vol.83 , pp. 1243-1252
    • Rothe, M.1    Pan, M.G.2    Henzel, W.J.3    Ayres, T.M.4    Goeddel, D.V.5
  • 106
    • 0037149542 scopus 로고    scopus 로고
    • TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2
    • Li, X.; Yang, Y.; Ashwell, J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature, 2002, 416, 345-347.
    • (2002) Nature , vol.416 , pp. 345-347
    • Li, X.1    Yang, Y.2    Ashwell, J.D.3
  • 107
    • 45449112944 scopus 로고    scopus 로고
    • Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells
    • Gerlo, S.; Haegeman, G.; Vanden Berghe, W. Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells. Cell. Signal., 2008, 20, 1489-1496.
    • (2008) Cell. Signal , vol.20 , pp. 1489-1496
    • Gerlo, S.1    Haegeman, G.2    Vanden, B.W.3
  • 108
    • 0030041147 scopus 로고    scopus 로고
    • Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B
    • Chauhan, D.; Uchiyama, H.; Akbarali, Y.; Urashima, M.; Yamamoto, K.; Libermann, T.A.; Anderson, K.C. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood, 1996, 87, 1104-1112.
    • (1996) Blood , vol.87 , pp. 1104-1112
    • Chauhan, D.1    Uchiyama, H.2    Akbarali, Y.3    Urashima, M.4    Yamamoto, K.5    Libermann, T.A.6    Anderson, K.C.7
  • 110
    • 0030057701 scopus 로고    scopus 로고
    • Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group
    • Pulkki, K.; Pelliniemi, T.T.; Rajamäki, A.; Tienhaara, A.; Laakso, M.; Lahtinen, R. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group. Br. J. Haematol., 1996, 92, 370-374.
    • (1996) Br. J. Haematol , vol.92 , pp. 370-374
    • Pulkki, K.1    Pelliniemi, T.T.2    Rajamäki, A.3    Tienhaara, A.4    Laakso, M.5    Lahtinen, R.6
  • 111
    • 0028331014 scopus 로고
    • Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice
    • Fattori, E.; Della Rocca, C.; Costa, P.; Giorgio, M.; Dente, B.; Pozzi, L.; Ciliberto, G. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood, 1994, 83, 2570-2579.
    • (1994) Blood , vol.83 , pp. 2570-2579
    • Fattori, E.1    della Rocca, C.2    Costa, P.3    Giorgio, M.4    Dente, B.5    Pozzi, L.6    Ciliberto, G.7
  • 112
    • 0025139463 scopus 로고
    • NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene
    • Schreck, R.; Baeuerle, P.A. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol., 1990, 10, 1281-1286.
    • (1990) Mol. Cell. Biol , vol.10 , pp. 1281-1286
    • Schreck, R.1    Baeuerle, P.A.2
  • 113
    • 0025633094 scopus 로고
    • Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells
    • Zhang, X.G.; Bataille, R.; Jourdan, M.; Saeland, S.; Banchereau, J.; Mannoni, P.; Klein B. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 1990, 76, 2599-2605.
    • (1990) Blood , vol.76 , pp. 2599-2605
    • Zhang, X.G.1    Bataille, R.2    Jourdan, M.3    Saeland, S.4    Banchereau, J.5    Mannoni, P.6    Klein, B.7
  • 114
    • 0031686759 scopus 로고    scopus 로고
    • Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity
    • Villunger, A.; Egle, A.; Kos, M.; Egle, D.; Tinhofer, I.; Henn, T.; Uberall, F.; Maly, K.; Greil, R. Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity. Br. J. Haematol., 1998, 102, 1069-1080.
    • (1998) Br. J. Haematol , vol.102 , pp. 1069-1080
    • Villunger, A.1    Egle, A.2    Kos, M.3    Egle, D.4    Tinhofer, I.5    Henn, T.6    Uberall, F.7    Maly, K.8    Greil, R.9
  • 119
    • 58149185114 scopus 로고    scopus 로고
    • Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production
    • Abe, M.; Hiura, K.; Ozaki, S.; Kido, S.; Matsumoto, T. Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production. J. Bone Miner. Metab., 2009, 27, 16-23.
    • (2009) J. Bone Miner. Metab , vol.27 , pp. 16-23
    • Abe, M.1    Hiura, K.2    Ozaki, S.3    Kido, S.4    Matsumoto, T.5
  • 120
    • 0028899112 scopus 로고
    • Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line
    • Lee, H.; Arsura, M.; Wu, M.; Duyao, M.; Buckler, A.J.; Sonenshein, G.E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med., 1995, 181, 1169-1177.
    • (1995) J. Exp. Med , vol.181 , pp. 1169-1177
    • Lee, H.1    Arsura, M.2    Wu, M.3    Duyao, M.4    Buckler, A.J.5    Sonenshein, G.E.6
  • 121
    • 0032588186 scopus 로고    scopus 로고
    • NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
    • Guttridge, D.C.; Albanese, C.; Reuther, J.Y.; Pestell, RG.; Baldwin, A.S. Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol., 1999, 19, 5785-5799.
    • (1999) Mol. Cell. Biol , vol.19 , pp. 5785-5799
    • Guttridge, D.C.1    Albanese, C.2    Reuther, J.Y.3    Pestell, R.G.4    Baldwin Jr., A.S.5
  • 122
    • 0032588170 scopus 로고    scopus 로고
    • NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
    • Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol., 1999, 19, 2690-2698.
    • (1999) Mol. Cell. Biol , vol.19 , pp. 2690-2698
    • Hinz, M.1    Krappmann, D.2    Eichten, A.3    Heder, A.4    Scheidereit, C.5    Strauss, M.6
  • 126
    • 22044440425 scopus 로고    scopus 로고
    • Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma
    • Bergsagel P.L.; Kuehl, W.M.; Zhan, F.; Sawyer, J.; Barlogie, B.; Shaughnessy, J. Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 2005, 106, 296-303.
    • (2005) Blood , vol.106 , pp. 296-303
    • Bergsagel, P.L.1    Kuehl, W.M.2    Zhan, F.3    Sawyer, J.4    Barlogie, B.5    Shaughnessy Jr., J.6
  • 127
    • 0033529416 scopus 로고    scopus 로고
    • NF-κBmediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
    • Lee, H.H.; Dadgostar, H.; Cheng, Q.; Shu, J.; Cheng, G. NF-κBmediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA, 1999, 96, 9136-9141.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 9136-9141
    • Lee, H.H.1    Dadgostar, H.2    Cheng, Q.3    Shu, J.4    Cheng, G.5
  • 128
    • 0032490670 scopus 로고    scopus 로고
    • Nuclear factor (NF)-kappaB-regulated Xchromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis
    • Stehlik, C.; de Martin, R.; Kumabashiri, I.; Schmid, J.A.; Binder, B.R.; Lipp, J. Nuclear factor (NF)-kappaB-regulated Xchromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med., 1998, 188, 211-216.
    • (1998) J. Exp. Med , vol.188 , pp. 211-216
    • Stehlik, C.1    de Martin, R.2    Kumabashiri, I.3    Schmid, J.A.4    Binder, B.R.5    Lipp, J.6
  • 129
    • 0032531994 scopus 로고    scopus 로고
    • Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells
    • Hu, X.; Yee, E.; Harlan, J.M.; Wong, F.; Karsan, A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood, 1998, 92, 2759-2765.
    • (1998) Blood , vol.92 , pp. 2759-2765
    • Hu, X.1    Yee, E.2    Harlan, J.M.3    Wong, F.4    Karsan, A.5
  • 130
    • 0032508414 scopus 로고    scopus 로고
    • NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
    • Wang, C.Y.; Mayo, M.W.; Korneluk, R.G.; Goeddel, D.V.; Baldwin, A.S. Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 1998, 281, 1680-1683.
    • (1998) Science , vol.281 , pp. 1680-1683
    • Wang, C.Y.1    Mayo, M.W.2    Korneluk, R.G.3    Goeddel, D.V.4    Baldwin Jr., A.S.5
  • 131
    • 1842425016 scopus 로고    scopus 로고
    • Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies
    • Panwalkar, A.; Verstovsek, S.; Giles, F. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Cancer, 2004, 100, 1578-1589.
    • (2004) Cancer , vol.100 , pp. 1578-1589
    • Panwalkar, A.1    Verstovsek, S.2    Giles, F.3
  • 134
    • 33750589355 scopus 로고    scopus 로고
    • IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes
    • Nakagawa, Y.; Abe, S.; Kurata, M.; Hasegawa, M.; Yamamoto, K.; Inoue, M.; Takemura, T.; Suzuki, K.; Kitagawa, M. IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. Am. J. Hematol., 2006, 81, 824-831.
    • (2006) Am. J. Hematol , vol.81 , pp. 824-831
    • Nakagawa, Y.1    Abe, S.2    Kurata, M.3    Hasegawa, M.4    Yamamoto, K.5    Inoue, M.6    Takemura, T.7    Suzuki, K.8    Kitagawa, M.9
  • 137
    • 0037442674 scopus 로고    scopus 로고
    • VEGF expression in human macrophages is NFkappaB-dependent: Studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinasedefective form of the IkappaB kinase 2
    • Kiriakidis, S.; Andreakos, E.; Monaco, C.; Foxwell, B.; Feldmann, M.; Paleolog, E. VEGF expression in human macrophages is NFkappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinasedefective form of the IkappaB kinase 2. J. Cell. Sci., 2003, 116, 665-674.
    • (2003) J. Cell. Sci , vol.116 , pp. 665-674
    • Kiriakidis, S.1    Andreakos, E.2    Monaco, C.3    Foxwell, B.4    Feldmann, M.5    Paleolog, E.6
  • 138
    • 26844516068 scopus 로고    scopus 로고
    • NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells
    • Cramer, M.; Nagy, I.; Murphy, B.J.; Gassmann, M.; Hottiger, M.O.; Georgiev, O.; Schaffner, W. NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol. Chem., 2005, 386, 865-872.
    • (2005) Biol. Chem , vol.386 , pp. 865-872
    • Cramer, M.1    Nagy, I.2    Murphy, B.J.3    Gassmann, M.4    Hottiger, M.O.5    Georgiev, O.6    Schaffner, W.7
  • 139
    • 28844501340 scopus 로고    scopus 로고
    • The role of nuclear factor kappaB on angiogenesis regulation through monocyte chemotactic protein-1 in myeloma
    • Stifter, S. The role of nuclear factor kappaB on angiogenesis regulation through monocyte chemotactic protein-1 in myeloma. Med. Hypotheses, 2006, 66, 384-386.
    • (2006) Med. Hypotheses , vol.66 , pp. 384-386
    • Stifter, S.1
  • 141
    • 0034981119 scopus 로고    scopus 로고
    • VLA-4-dependent myeloma cell adhesion
    • Sanz-Rodríguez, F.; Teixidó, J. VLA-4-dependent myeloma cell adhesion. Leuk. Lymphoma, 2001, 41, 239-245.
    • (2001) Leuk. Lymphoma , vol.41 , pp. 239-245
    • Sanz-Rodríguez, F.1    Teixidó, J.2
  • 142
    • 0032508674 scopus 로고    scopus 로고
    • Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B
    • Bond, M.; Fabunmi, R.P.; Baker, A.H.; Newby, A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett., 1998, 435, 29-34.
    • (1998) FEBS Lett , vol.435 , pp. 29-34
    • Bond, M.1    Fabunmi, R.P.2    Baker, A.H.3    Newby, A.C.4
  • 143
    • 0031596140 scopus 로고    scopus 로고
    • Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts
    • Vincenti, M.P.; Coon, C.I.; Brinckerhoff, C.E. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum., 1998, 41, 1987-1994.
    • (1998) Arthritis Rheum , vol.41 , pp. 1987-1994
    • Vincenti, M.P.1    Coon, C.I.2    Brinckerhoff, C.E.3
  • 144
    • 39449098165 scopus 로고    scopus 로고
    • Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA)
    • Hecht, M.; von Metzler, I.; Sack, K.; Kaiser, M.; Sezer, O. Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA). Exp. Cell. Res., 2008, 314, 1082-1093.
    • (2008) Exp. Cell. Res , vol.314 , pp. 1082-1093
    • Hecht, M.1    von Metzler, I.2    Sack, K.3    Kaiser, M.4    Sezer, O.5
  • 145
    • 0038780897 scopus 로고    scopus 로고
    • Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
    • Delaissé, J.M.; Andersen, T.L.; Engsig, M.T.; Henriksen, K.; Troen, T.; Blavier, L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc. Res. Tech., 2003, 61, 504-513.
    • (2003) Microsc. Res. Tech , vol.61 , pp. 504-513
    • Delaissé, J.M.1    Andersen, T.L.2    Engsig, M.T.3    Henriksen, K.4    Troen, T.5    Blavier, L.6
  • 148
    • 1642278407 scopus 로고    scopus 로고
    • Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells
    • Dai, Y.; Pei, X.Y.; Rahmani, M.; Conrad, D.H.; Dent, P.; Grant, S. Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells. Blood, 2004, 103, 2761-2770.
    • (2004) Blood , vol.103 , pp. 2761-2770
    • Dai, Y.1    Pei, X.Y.2    Rahmani, M.3    Conrad, D.H.4    Dent, P.5    Grant, S.6
  • 150
    • 35948980027 scopus 로고    scopus 로고
    • Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL
    • Romagnoli, M.; Desplanques, G.; Maïga, S.; Legouill, S.; Dreano, M.; Bataille, R.; Barillé-Nion, S. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL. Clin. Cancer Res., 2007, 13, 6010-6018.
    • (2007) Clin. Cancer Res , vol.13 , pp. 6010-6018
    • Romagnoli, M.1    Desplanques, G.2    Maïga, S.3    Legouill, S.4    Dreano, M.5    Bataille, R.6    Barillé-Nion, S.7
  • 152
    • 54049149951 scopus 로고    scopus 로고
    • Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells
    • Malara, N.; Focà, D.; Casadonte, F.; Sesto, M.F.; Macrina, L.; Santoro, L.; Scaramuzzino, M.; Terracciano, R.; Savino, R. Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells. Cell Cycle, 2008, 7, 3235-3245.
    • (2008) Cell Cycle , vol.7 , pp. 3235-3245
    • Malara, N.1    Focà, D.2    Casadonte, F.3    Sesto, M.F.4    Macrina, L.5    Santoro, L.6    Scaramuzzino, M.7    Terracciano, R.8    Savino, R.9
  • 153
    • 8444220061 scopus 로고    scopus 로고
    • Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells
    • Yinjun, L.; Jie, J.; Yungui, W. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk. Res., 2005, 29, 99-105.
    • (2005) Leuk. Res , vol.29 , pp. 99-105
    • Yinjun, L.1    Jie, J.2    Yungui, W.3
  • 154
    • 33646355210 scopus 로고    scopus 로고
    • Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide
    • Wang, X.; Matta, R.; Shen, G.; Nelin, L.D.; Pei, D.; Liu, Y. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J. Mol. Med., 2006, 84, 405-415.
    • (2006) J. Mol. Med , vol.84 , pp. 405-415
    • Wang, X.1    Matta, R.2    Shen, G.3    Nelin, L.D.4    Pei, D.5    Liu, Y.6
  • 155
    • 33845868505 scopus 로고    scopus 로고
    • The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages
    • Bao, X.; Cui, J.; Wu, Y.; Han, X.; Gao, C.; Hua, Z.; Shen, P. The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages. J. Mol. Med., 2007, 85, 85-98.
    • (2007) J. Mol. Med , vol.85 , pp. 85-98
    • Bao, X.1    Cui, J.2    Wu, Y.3    Han, X.4    Gao, C.5    Hua, Z.6    Shen, P.7
  • 156
    • 65449174330 scopus 로고    scopus 로고
    • Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-{kappa}B with anti-myeloma activity in vitro and in vivo
    • Tiedemann, R.E.; Schmidt, J.; Keats, J.J.; Shi, C.X.; Zhu, Y.X.; Palmer, S.E.; Mao, X.; Schimmer, A.D.; Stewart, A.K. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-{kappa}B with anti-myeloma activity in vitro and in vivo. Blood, 2009, 113, 4027-4037.
    • (2009) Blood , vol.113 , pp. 4027-4037
    • Tiedemann, R.E.1    Schmidt, J.2    Keats, J.J.3    Shi, C.X.4    Zhu, Y.X.5    Palmer, S.E.6    Mao, X.7    Schimmer, A.D.8    Stewart, A.K.9
  • 157
    • 2342613652 scopus 로고    scopus 로고
    • The proteasome: A suitable antineoplastic target
    • Adams, J. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer, 2004, 4, 349-360.
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 349-360
    • Adams, J.1
  • 158
    • 0345447210 scopus 로고    scopus 로고
    • Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy
    • Kane, R.C.; Bross, P.F.; Farrell, A.T.; Pazdur, R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist, 2003, 8, 508-513.
    • (2003) Oncologist , vol.8 , pp. 508-513
    • Kane, R.C.1    Bross, P.F.2    Farrell, A.T.3    Pazdur, R.4
  • 159
    • 33744832401 scopus 로고    scopus 로고
    • United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
    • Kane, R.C.; Farrell, A.T.; Sridhara, R.; Pazdur, R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin. Cancer Res., 2006, 12, 2955-2960.
    • (2006) Clin. Cancer Res , vol.12 , pp. 2955-2960
    • Kane, R.C.1    Farrell, A.T.2    Sridhara, R.3    Pazdur, R.4
  • 162
    • 43249127114 scopus 로고    scopus 로고
    • Targeting proteasomes as therapy in multiple myeloma
    • Chauhan, D.; Hideshima, T.; Anderson, K.C. Targeting proteasomes as therapy in multiple myeloma. Adv. Exp. Med. Biol., 2008, 615, 251-260.
    • (2008) Adv. Exp. Med. Biol , vol.615 , pp. 251-260
    • Chauhan, D.1    Hideshima, T.2    Anderson, K.C.3
  • 165
    • 43049115407 scopus 로고    scopus 로고
    • Bortezomib in mantle cell lymphoma
    • Suh, K.S.; Gay, A. Bortezomib in mantle cell lymphoma. Future Oncol., 2008, 4, 149-168.
    • (2008) Future Oncol , vol.4 , pp. 149-168
    • Suh, K.S.1    Gay, A.2
  • 166
    • 0035300479 scopus 로고    scopus 로고
    • The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
    • Hideshima, T.; Richardson, P.; Chauhan, D.; Palombella, V.J.; Elliott, P.J.; Adams, J.; Anderson, K.C. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res., 2001, 61, 3071-3076.
    • (2001) Cancer Res , vol.61 , pp. 3071-3076
    • Hideshima, T.1    Richardson, P.2    Chauhan, D.3    Palombella, V.J.4    Elliott, P.J.5    Adams, J.6    Anderson, K.C.7
  • 168
    • 0037455147 scopus 로고    scopus 로고
    • Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora
    • Feling, R.H.; Buchanan, G.O.; Mincer, T.J.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew. Chem. Int. Ed. Engl., 2003, 42, 355-357.
    • (2003) Angew. Chem. Int. Ed. Engl , vol.42 , pp. 355-357
    • Feling, R.H.1    Buchanan, G.O.2    Mincer, T.J.3    Kauffman, C.A.4    Jensen, P.R.5    Fenical, W.6
  • 171
    • 33750209537 scopus 로고    scopus 로고
    • A novel proteasome inhibitor NPI-0052 as an anticancer therapy
    • Chauhan, D.; Hideshima, T.; Anderson, K.C. A novel proteasome inhibitor NPI-0052 as an anticancer therapy. Br. J. Cancer, 2006, 95, 961-965.
    • (2006) Br. J. Cancer , vol.95 , pp. 961-965
    • Chauhan, D.1    Hideshima, T.2    Anderson, K.C.3
  • 173
  • 176
    • 41549133200 scopus 로고    scopus 로고
    • Proteasome inhibitors in cancer therapy: Lessons from the first decade
    • Orlowski, R.Z.; Kuhn, D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin. Cancer. Res., 2008, 14, 1649-1657.
    • (2008) Clin. Cancer. Res , vol.14 , pp. 1649-1657
    • Orlowski, R.Z.1    Kuhn, D.J.2
  • 179
    • 0021022219 scopus 로고
    • Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers
    • Demerson, C.A.; Humber, L.G.; Abraham, N.A.; Schilling, G.; Martel, R.R.; Pace-Asciak, C. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. J. Med. Chem., 1983, 26, 1778-1780.
    • (1983) J. Med. Chem , vol.26 , pp. 1778-1780
    • Demerson, C.A.1    Humber, L.G.2    Abraham, N.A.3    Schilling, G.4    Martel, R.R.5    Pace-Asciak, C.6
  • 180
    • 0022486909 scopus 로고
    • Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): A potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer
    • Humber, L.G.; Demerson, C.A. Swaminathan, P.; Bird, P.H. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer. J. Med. Chem., 1986, 29, 871-874.
    • (1986) J. Med. Chem , vol.29 , pp. 871-874
    • Humber, L.G.1    Demerson, C.A.2    Swaminathan, P.3    Bird, P.H.4
  • 183
    • 33847364101 scopus 로고    scopus 로고
    • SDX-308, a nonsteroidal antiinflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth
    • Feng, R.; Anderson, G.; Xiao, G.; Elliott, G.; Leoni, L.; Mapara, M.Y.; Roodman, G.D.; Lentzsch, S. SDX-308, a nonsteroidal antiinflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. Blood, 2007, 109, 2130-2138.
    • (2007) Blood , vol.109 , pp. 2130-2138
    • Feng, R.1    Anderson, G.2    Xiao, G.3    Elliott, G.4    Leoni, L.5    Mapara, M.Y.6    Roodman, G.D.7    Lentzsch, S.8
  • 184
    • 51349150407 scopus 로고    scopus 로고
    • The role of non-steroidal antiinflammatory drugs in the risk of development and treatment of hematologic malignancies
    • Robak, P.; Smolewski, P.; Robak, T. The role of non-steroidal antiinflammatory drugs in the risk of development and treatment of hematologic malignancies. Leuk. Lymphoma, 2008, 49, 1452-1462.
    • (2008) Leuk. Lymphoma , vol.49 , pp. 1452-1462
    • Robak, P.1    Smolewski, P.2    Robak, T.3
  • 187
  • 189
    • 74849125276 scopus 로고    scopus 로고
    • The pharmacological NFkappaB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation
    • Zanotto-Filho, A.; Delgado-Cañedo, A.; Schröder, R.; Becker, M.; Klamt, F.; Moreira, J.C. The pharmacological NFkappaB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation. Cancer Lett., 2010, 288, 192-203.
    • (2010) Cancer Lett , vol.288 , pp. 192-203
    • Zanotto-Filho, A.1    Delgado-Cañedo, A.2    Schröder, R.3    Becker, M.4    Klamt, F.5    Moreira, J.C.6
  • 191
    • 0028986985 scopus 로고
    • The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NFkappa B transcription factor in acute myeloblastic leukemia cells
    • Dokter, W.H.; Tuyt, L.; Sierdsema, S.J.; Esselink, M.T.; Vellenga, E. The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NFkappa B transcription factor in acute myeloblastic leukemia cells. Leukemia, 1995, 9, 425-432.
    • (1995) Leukemia , vol.9 , pp. 425-432
    • Dokter, W.H.1    Tuyt, L.2    Sierdsema, S.J.3    Esselink, M.T.4    Vellenga, E.5
  • 193
    • 0038040499 scopus 로고    scopus 로고
    • Effect of NF-kappaB/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells
    • Romano, M.F.; Petrella, A.; Bisogni, R.; Turco, M.C.; Venuta, S. Effect of NF-kappaB/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells. Leukemia, 2003, 17, 1190-1192.
    • (2003) Leukemia , vol.17 , pp. 1190-1192
    • Romano, M.F.1    Petrella, A.2    Bisogni, R.3    Turco, M.C.4    Venuta, S.5
  • 194
    • 0042744823 scopus 로고    scopus 로고
    • Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells
    • Estrov, Z.; Shishodia, S.; Faderl, S.; Harris, D.; Van, Q.; Kantarjian, H.M.; Talpaz, M.; Aggarwal, B.B. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 2003, 102, 987-995.
    • (2003) Blood , vol.102 , pp. 987-995
    • Estrov, Z.1    Shishodia, S.2    Faderl, S.3    Harris, D.4    Van, Q.5    Kantarjian, H.M.6    Talpaz, M.7    Aggarwal, B.B.8
  • 196
    • 43549095276 scopus 로고    scopus 로고
    • HO-1 underlies resistance of AML cells to TNF-induced apoptosis
    • Rushworth, S.A.; MacEwan, D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood, 2008, 111, 3793-3801.
    • (2008) Blood , vol.111 , pp. 3793-3801
    • Rushworth, S.A.1    Macewan, D.J.2
  • 197
    • 77950819906 scopus 로고    scopus 로고
    • NFkappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction
    • Rushworth, S.A.; Bowles, K.M.; Raninga, P.; MacEwan, D.J. NFkappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction. Cancer Res., 2010, 70, 2973-2983.
    • (2010) Cancer Res , vol.70 , pp. 2973-2983
    • Rushworth, S.A.1    Bowles, K.M.2    Raninga, P.3    Macewan, D.J.4
  • 199
    • 1042278138 scopus 로고    scopus 로고
    • Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: Abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9
    • Takada, Y.; Aggarwal, B.B. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J. Biol. Chem., 2004, 279, 4750-4759.
    • (2004) J. Biol. Chem , vol.279 , pp. 4750-4759
    • Takada, Y.1    Aggarwal, B.B.2
  • 200
    • 4844224868 scopus 로고    scopus 로고
    • Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol
    • Gao, N.; Dai, Y.; Rahmani, M.; Dent, P.; Grant, S. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol. Mol. Pharmacol., 2004, 66, 956-963.
    • (2004) Mol. Pharmacol , vol.66 , pp. 956-963
    • Gao, N.1    Dai, Y.2    Rahmani, M.3    Dent, P.4    Grant, S.5
  • 201
    • 77950620888 scopus 로고    scopus 로고
    • Exploiting cellular pathways to develop new treatment strategies for AML
    • Fathi, A.T.; Grant, S.; Karp, J.E. Exploiting cellular pathways to develop new treatment strategies for AML. Cancer Treat. Rev., 2010, 36, 142-150.
    • (2010) Cancer Treat. Rev , vol.36 , pp. 142-150
    • Fathi, A.T.1    Grant, S.2    Karp, J.E.3
  • 203
    • 16844363378 scopus 로고    scopus 로고
    • The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
    • Guzman, M.L.; Rossi, R.M.; Karnischky, L.; Li, X.; Peterson, D.R.; Howard, D.S.; Jordan, C.T. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood, 2005, 105, 4163-4169.
    • (2005) Blood , vol.105 , pp. 4163-4169
    • Guzman, M.L.1    Rossi, R.M.2    Karnischky, L.3    Li, X.4    Peterson, D.R.5    Howard, D.S.6    Jordan, C.T.7
  • 204
    • 47049105891 scopus 로고    scopus 로고
    • Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data
    • Hassane, D.C.; Guzman, M.L.; Corbett, C.; Li, X.; Abboud, R.; Young, F.; Liesveld, J.L.; Carroll, M.; Jordan, C.T. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood, 2008, 111, 5654-5662.
    • (2008) Blood , vol.111 , pp. 5654-5662
    • Hassane, D.C.1    Guzman, M.L.2    Corbett, C.3    Li, X.4    Abboud, R.5    Young, F.6    Liesveld, J.L.7    Carroll, M.8    Jordan, C.T.9
  • 205
    • 0036081355 scopus 로고    scopus 로고
    • Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
    • Edgar, R.; Domrachev, M.; Lash, A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 2002, 30, 207-210.
    • (2002) Nucleic Acids Res , vol.30 , pp. 207-210
    • Edgar, R.1    Domrachev, M.2    Lash, A.E.3
  • 206
    • 0033597234 scopus 로고    scopus 로고
    • 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis
    • Page, S.; Fischer, C.; Baumgartner, B.; Haas, M.; Kreusel, U.; Loidl, G.; Hayn, M.; Ziegler-Heitbrock, H.W.; Neumeier, D.; Brand, K. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J. Biol. Chem., 1999, 274, 11611-11618.
    • (1999) J. Biol. Chem , vol.274 , pp. 11611-11618
    • Page, S.1    Fischer, C.2    Baumgartner, B.3    Haas, M.4    Kreusel, U.5    Loidl, G.6    Hayn, M.7    Ziegler-Heitbrock, H.W.8    Neumeier, D.9    Brand, K.10
  • 207
    • 0035947678 scopus 로고    scopus 로고
    • IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal
    • Ji, C.; Kozak, K.R.; Marnett, L.J. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem., 2001, 276, 18223-18228.
    • (2001) J. Biol. Chem , vol.276 , pp. 18223-18228
    • Ji, C.1    Kozak, K.R.2    Marnett, L.J.3
  • 208
    • 0037411282 scopus 로고    scopus 로고
    • 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress
    • Uchida, K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res., 2003, 42, 318-343.
    • (2003) Prog. Lipid Res , vol.42 , pp. 318-343
    • Uchida, K.1
  • 209
    • 19544390715 scopus 로고    scopus 로고
    • Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects
    • Setty, A.R.; Sigal, L.H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin. Arthritis Rheum., 2005, 34, 773-784.
    • (2005) Semin. Arthritis Rheum , vol.34 , pp. 773-784
    • Setty, A.R.1    Sigal, L.H.2
  • 210
    • 33750008443 scopus 로고    scopus 로고
    • Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid
    • Lee, J.H.; Koo, T.H.; Yoon, H.; Jung, H.S.; Jin, H.Z.; Lee, K.; Hong, Y.S.; Lee, J.J. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem. Pharmacol., 2006, 72, 1311-1321.
    • (2006) Biochem. Pharmacol , vol.72 , pp. 1311-1321
    • Lee, J.H.1    Koo, T.H.2    Yoon, H.3    Jung, H.S.4    Jin, H.Z.5    Lee, K.6    Hong, Y.S.7    Lee, J.J.8
  • 211
    • 33646406554 scopus 로고    scopus 로고
    • Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
    • Yang, H.; Chen, D.; Cui, Q.C.; Yuan, X.; Dou, Q.P. Celastrol, a triterpene extracted from the Chinese Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res., 2006, 66, 4758-4765.
    • (2006) Cancer Res , vol.66 , pp. 4758-4765
    • Yang, H.1    Chen, D.2    Cui, Q.C.3    Yuan, X.4    Dou, Q.P.5
  • 213
    • 0242493856 scopus 로고    scopus 로고
    • The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571
    • Yu, C.; Rahmani, M.; Conrad, D.; Subler, M.; Dent, P.; Grant, S. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. Blood, 2003, 102, 3765-3774.
    • (2003) Blood , vol.102 , pp. 3765-3774
    • Yu, C.1    Rahmani, M.2    Conrad, D.3    Subler, M.4    Dent, P.5    Grant, S.6
  • 214
    • 3142554015 scopus 로고    scopus 로고
    • Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and-independent mechanisms
    • Dai, Y.; Rahmani, M.; Pei, X.Y.; Dent, P.; Grant, S. Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and-independent mechanisms. Blood, 2004, 104, 509-518.
    • (2004) Blood , vol.104 , pp. 509-518
    • Dai, Y.1    Rahmani, M.2    Pei, X.Y.3    Dent, P.4    Grant, S.5
  • 215
    • 35648974809 scopus 로고    scopus 로고
    • AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies
    • Dell'Eva, R.; Ambrosini, C.; Vannini, N.; Piaggio, G.; Albini, A.; Ferrari, N. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer, 2007, 110, 2007-2011.
    • (2007) Cancer , vol.110 , pp. 2007-2011
    • Dell'Eva, R.1    Ambrosini, C.2    Vannini, N.3    Piaggio, G.4    Albini, A.5    Ferrari, N.6
  • 217
    • 70249121052 scopus 로고    scopus 로고
    • The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NFkappaB pathway
    • Wei, Y.L.; Liang, Y.; Xu, L.; Zhao, X.Y. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NFkappaB pathway. Anat. Rec. (Hoboken), 2009, 292, 945-950.
    • (2009) Anat. Rec. (Hoboken) , vol.292 , pp. 945-950
    • Wei, Y.L.1    Liang, Y.2    Xu, L.3    Zhao, X.Y.4
  • 218
    • 65249094734 scopus 로고    scopus 로고
    • Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
    • Wei, Y.L.; Xu, L.; Liang, Y.; Xu, X.H.; Zhao, X.Y. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Acta Pharmacol. Sin., 2009, 30, 451-457.
    • (2009) Acta Pharmacol. Sin , vol.30 , pp. 451-457
    • Wei, Y.L.1    Xu, L.2    Liang, Y.3    Xu, X.H.4    Zhao, X.Y.5
  • 219
    • 67349250886 scopus 로고    scopus 로고
    • Berbamine derivatives: A novel class of compounds for antileukemia activity
    • Xie, J.; Ma, T.; Gu, Y.; Zhang, X.; Qiu, X.; Zhang, L.; Xu, R.; Yu, Y. Berbamine derivatives: a novel class of compounds for antileukemia activity. Eur. J. Med. Chem., 2009, 44, 3293-3298.
    • (2009) Eur. J. Med. Chem , vol.44 , pp. 3293-3298
    • Xie, J.1    Ma, T.2    Gu, Y.3    Zhang, X.4    Qiu, X.5    Zhang, L.6    Xu, R.7    Yu, Y.8
  • 222
    • 73949158411 scopus 로고    scopus 로고
    • High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia
    • Herling, M.; Patel, K.A.; Weit, N.; Lilienthal, N.; Hallek, M.; Keating, M.J.; Jones, D. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood, 2009, 114, 4675-4686.
    • (2009) Blood , vol.114 , pp. 4675-4686
    • Herling, M.1    Patel, K.A.2    Weit, N.3    Lilienthal, N.4    Hallek, M.5    Keating, M.J.6    Jones, D.7
  • 224
    • 0033621706 scopus 로고    scopus 로고
    • CD40 and B chronic lymphocytic leukemia cell response to fludarabine: The influence of NF-kappaB/Rel transcription factors on chemotherapyinduced apoptosis
    • Romano, M.F.; Lamberti, A.; Turco, M.C.; Venuta, S. CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapyinduced apoptosis. Leuk. Lymphoma, 2000, 36, 255-262.
    • (2000) Leuk. Lymphoma , vol.36 , pp. 255-262
    • Romano, M.F.1    Lamberti, A.2    Turco, M.C.3    Venuta, S.4
  • 227
    • 77149154324 scopus 로고    scopus 로고
    • NF-kappaB as a therapeutic target in chronic lymphocytic leukemia
    • Lopez-Guerra, M.; Colomer, D. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia. Expert Opin. Ther. Targets, 2010, 14, 275-288.
    • (2010) Expert Opin. Ther. Targets , vol.14 , pp. 275-288
    • Lopez-Guerra, M.1    Colomer, D.2
  • 228
    • 0034005455 scopus 로고    scopus 로고
    • CD40 ligand in CLL pathogenesis and therapy
    • Schattner, E.J. CD40 ligand in CLL pathogenesis and therapy. Leuk. Lymphoma, 2000, 37, 461-472.
    • (2000) Leuk. Lymphoma , vol.37 , pp. 461-472
    • Schattner, E.J.1
  • 229
    • 33750454819 scopus 로고    scopus 로고
    • Mutations in the NF-kappaB signaling pathway: Implications for human disease
    • Courtois, G.; Gilmore, T.D. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene, 2006, 25, 6831-6843.
    • (2006) Oncogene , vol.25 , pp. 6831-6843
    • Courtois, G.1    Gilmore, T.D.2
  • 230
    • 0034651739 scopus 로고    scopus 로고
    • Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells
    • Furman, R.R.; Asgary, Z.; Mascarenhas, J.O.; Liou, H.C.; Schattner, E.J. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J. Immunol., 2000, 164, 2200-2206.
    • (2000) J. Immunol , vol.164 , pp. 2200-2206
    • Furman, R.R.1    Asgary, Z.2    Mascarenhas, J.O.3    Liou, H.C.4    Schattner, E.J.5
  • 231
    • 34547130063 scopus 로고    scopus 로고
    • CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis
    • Mineva, N.D.; Rothstein, T.L.; Meyers, J.A.; Lerner, A.; Sonenshein, G.E. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J. Biol. Chem., 2007, 282, 17475-17485.
    • (2007) J. Biol. Chem , vol.282 , pp. 17475-17485
    • Mineva, N.D.1    Rothstein, T.L.2    Meyers, J.A.3    Lerner, A.4    Sonenshein, G.E.5
  • 232
    • 2542527768 scopus 로고    scopus 로고
    • Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways
    • Zarnegar, B.; He, J.Q.; Oganesyan, G.; Hoffmann, A.; Baltimore, D.; Cheng, G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. USA, 2004, 101, 8108-8113.
    • (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 8108-8113
    • Zarnegar, B.1    He, J.Q.2    Oganesyan, G.3    Hoffmann, A.4    Baltimore, D.5    Cheng, G.6
  • 233
    • 34547114509 scopus 로고    scopus 로고
    • Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells
    • Ougolkov, A.V.; Bone, N.D.; Fernandez-Zapico, M.E.; Kay, N.E.; Billadeau, D.D. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. Blood, 2007, 110, 735-742.
    • (2007) Blood , vol.110 , pp. 735-742
    • Ougolkov, A.V.1    Bone, N.D.2    Fernandez-Zapico, M.E.3    Kay, N.E.4    Billadeau, D.D.5
  • 234
    • 36849078197 scopus 로고    scopus 로고
    • Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration
    • Chen, H.; Yang, S.; Yang, Z.; Ma, L.; Jiang, D.; Mao, J.; Jiao, B.; Cai, Z. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration. J. Cell. Biochem., 2007, 102, 1281-1289.
    • (2007) J. Cell. Biochem , vol.102 , pp. 1281-1289
    • Chen, H.1    Yang, S.2    Yang, Z.3    Ma, L.4    Jiang, D.5    Mao, J.6    Jiao, B.7    Cai, Z.8
  • 237
    • 0037166268 scopus 로고    scopus 로고
    • Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNAbinding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes
    • Lee, J.H.; Koo, T.H.; Hwang, B.Y.; Lee, J.J. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNAbinding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J. Biol. Chem., 2002, 277, 18411-18420.
    • (2002) J. Biol. Chem , vol.277 , pp. 18411-18420
    • Lee, J.H.1    Koo, T.H.2    Hwang, B.Y.3    Lee, J.J.4
  • 238
    • 0035869378 scopus 로고    scopus 로고
    • CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia
    • Matrai, Z.; Lin, K.; Dennis, M.; Sherrington, P.; Zuzel, M.; Pettitt, A.R.; Cawley, J.C. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood, 2001, 97, 1902-1903.
    • (2001) Blood , vol.97 , pp. 1902-1903
    • Matrai, Z.1    Lin, K.2    Dennis, M.3    Sherrington, P.4    Zuzel, M.5    Pettitt, A.R.6    Cawley, J.C.7
  • 239
    • 65249086258 scopus 로고    scopus 로고
    • P65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541
    • López-Guerra, M.; Roué, G.; Pérez-Galán, P.; Alonso, R.; Villamor, N.; Montserrat, E.; Campo, E.; Colomer, D. P65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541. Clin. Cancer Res., 2009, 15, 2767-2776.
    • (2009) Clin. Cancer Res , vol.15 , pp. 2767-2776
    • López-Guerra, M.1    Roué, G.2    Pérez-Galán, P.3    Alonso, R.4    Villamor, N.5    Montserrat, E.6    Campo, E.7    Colomer, D.8
  • 240
  • 241
    • 63149189848 scopus 로고    scopus 로고
    • Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG
    • Ghosh, A.K.; Kay, N.E.; Secreto, C.R.; Shanafelt, T.D. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin. Cancer Res., 2009, 15, 1250-1258.
    • (2009) Clin. Cancer Res , vol.15 , pp. 1250-1258
    • Ghosh, A.K.1    Kay, N.E.2    Secreto, C.R.3    Shanafelt, T.D.4
  • 242
    • 68449098158 scopus 로고    scopus 로고
    • Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. Leuk
    • Hayun, R.; Okun, E.; Berrebi, A.; Shvidel, L.; Bassous, L.; Sredni, B.; Nir, U. Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. Leuk. Lymphoma, 2009, 50, 625-632.
    • (2009) Lymphoma , vol.50 , pp. 625-632
    • Hayun, R.1    Okun, E.2    Berrebi, A.3    Shvidel, L.4    Bassous, L.5    Sredni, B.6    Nir, U.7
  • 244
    • 0035324928 scopus 로고    scopus 로고
    • Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells
    • Hinz, M.; Löser, P.; Mathas, S.; Krappmann, D.; Dörken, B.; Scheidereit, C. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood, 2001, 97, 2798-2807.
    • (2001) Blood , vol.97 , pp. 2798-2807
    • Hinz, M.1    Löser, P.2    Mathas, S.3    Krappmann, D.4    Dörken, B.5    Scheidereit, C.6
  • 245
    • 20544465128 scopus 로고    scopus 로고
    • Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts
    • Nonaka, M.; Horie, R.; Itoh, K.; Watanabe, T.; Yamamoto, N.; Yamaoka, S. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts. Oncogene, 2005, 24, 3976-3986.
    • (2005) Oncogene , vol.24 , pp. 3976-3986
    • Nonaka, M.1    Horie, R.2    Itoh, K.3    Watanabe, T.4    Yamamoto, N.5    Yamaoka, S.6
  • 247
    • 70349459622 scopus 로고    scopus 로고
    • TNF receptor-associated factor 1 is a positive regulator of the NFkappaB alternative pathway
    • Lavorgna, A.; De Filippi, R.; Formisano, S.; Leonardi, A. TNF receptor-associated factor 1 is a positive regulator of the NFkappaB alternative pathway. Mol. Immunol., 2009, 46, 3278-3282.
    • (2009) Mol. Immunol , vol.46 , pp. 3278-3282
    • Lavorgna, A.1    de Filippi, R.2    Formisano, S.3    Leonardi, A.4
  • 249
    • 57049183997 scopus 로고    scopus 로고
    • Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies
    • Pavan, A.; Spina, M.; Canzonieri, V.; Sansonno, S.; Toffoli, G.; De Re, V. Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk. Lymphoma, 2008, 49, 2048-2058.
    • (2008) Leuk. Lymphoma , vol.49 , pp. 2048-2058
    • Pavan, A.1    Spina, M.2    Canzonieri, V.3    Sansonno, S.4    Toffoli, G.5    de Re, V.6
  • 251
    • 19944428834 scopus 로고    scopus 로고
    • Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling
    • Lam, L.T.; Davis, R.E.; Pierce, J.; Hepperle, M.; Xu, Y.; Hottelet, M.; Nong, Y.; Wen, D.; Adams, J.; Dang, L.; Staudt, L.M. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin. Cancer Res., 2005, 11, 28-40.
    • (2005) Clin. Cancer Res , vol.11 , pp. 28-40
    • Lam, L.T.1    Davis, R.E.2    Pierce, J.3    Hepperle, M.4    Xu, Y.5    Hottelet, M.6    Nong, Y.7    Wen, D.8    Adams, J.9    Dang, L.10    Staudt, L.M.11
  • 252
    • 43949131788 scopus 로고    scopus 로고
    • Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells
    • Mackenzie, G.G.; Queisser, N.; Wolfson, M.L.; Fraga, C.G.; Adamo, A.M.; Oteiza, P.I. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int. J. Cancer, 2008, 123, 56-65.
    • (2008) Int. J. Cancer , vol.123 , pp. 56-65
    • Mackenzie, G.G.1    Queisser, N.2    Wolfson, M.L.3    Fraga, C.G.4    Adamo, A.M.5    Oteiza, P.I.6
  • 253
    • 23044479821 scopus 로고    scopus 로고
    • Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
    • Shishodia, S.; Amin, H.M.; Lai, R.; Aggarwal, B.B. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol., 2005, 70, 700-713.
    • (2005) Biochem. Pharmacol , vol.70 , pp. 700-713
    • Shishodia, S.1    Amin, H.M.2    Lai, R.3    Aggarwal, B.B.4
  • 254
    • 40649105973 scopus 로고    scopus 로고
    • Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations
    • Mackenzie, G.G.; Adamo, A.M.; Decker, N.P.; Oteiza, P.I. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations. Biochem. Pharmacol., 2008, 75, 1461-1471.
    • (2008) Biochem. Pharmacol , vol.75 , pp. 1461-1471
    • Mackenzie, G.G.1    Adamo, A.M.2    Decker, N.P.3    Oteiza, P.I.4
  • 255
    • 33749257325 scopus 로고    scopus 로고
    • Modulation of transcription factor NF-kappaB in Hodgkin's lymphoma cell lines: Effect of (-)-epicatechin
    • Mackenzie, G.G.; Oteiza, P.I. Modulation of transcription factor NF-kappaB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin. Free Radic. Res., 2006, 40, 1086-1094.
    • (2006) Free Radic. Res , vol.40 , pp. 1086-1094
    • Mackenzie, G.G.1    Oteiza, P.I.2
  • 256
    • 33846476267 scopus 로고    scopus 로고
    • Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level
    • Roué, G.; Pérez-Galán, P.; López-Guerra, M.; Villamor, N.; Campo, E.; Colomer, D. Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level. J. Immunol., 2007, 178, 1923-1930.
    • (2007) J. Immunol , vol.178 , pp. 1923-1930
    • Roué, G.1    Pérez-Galán, P.2    López-Guerra, M.3    Villamor, N.4    Campo, E.5    Colomer, D.6
  • 257
    • 38949181015 scopus 로고    scopus 로고
    • Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma downregulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents
    • Sors, A.; Jean-Louis, F.; Bégué, E.; Parmentier, L.; Dubertret, L.; Dreano, M.; Courtois, G.; Bachelez, H.; Michel, L. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma downregulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clin. Cancer Res., 2008, 14, 901-911.
    • (2008) Clin. Cancer Res , vol.14 , pp. 901-911
    • Sors, A.1    Jean-Louis, F.2    Bégué, E.3    Parmentier, L.4    Dubertret, L.5    Dreano, M.6    Courtois, G.7    Bachelez, H.8    Michel, L.9
  • 258
    • 33748935149 scopus 로고    scopus 로고
    • Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma
    • Horie, R.; Watanabe, T.; Umezawa, K. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma. Drug News Perspect., 2006, 19, 201-209.
    • (2006) Drug News Perspect , vol.19 , pp. 201-209
    • Horie, R.1    Watanabe, T.2    Umezawa, K.3
  • 259
    • 0033929398 scopus 로고    scopus 로고
    • Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel-specific decoy oligodeoxynucleotides
    • Romano, M.F.; Lamberti, A.; Bisogni, R.; Tassone, P.; Pagnini, D.; Storti, G.; Del Vecchio, L.; Turco, M.C.; Venuta, S. Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel-specific decoy oligodeoxynucleotides. Gene Ther., 2000, 7, 1234-1237.
    • (2000) Gene Ther , vol.7 , pp. 1234-1237
    • Romano, M.F.1    Lamberti, A.2    Bisogni, R.3    Tassone, P.4    Pagnini, D.5    Storti, G.6    Del Vecchio, L.7    Turco, M.C.8    Venuta, S.9
  • 261
    • 0141953974 scopus 로고    scopus 로고
    • Transcription factors as molecular targets: Molecular mechanisms of decoy ODN and their design
    • Tomita, N.; Ogihara, T.; Morishita, R. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design. Curr. Drug Targets, 2003, 4, 603-608.
    • (2003) Curr. Drug Targets , vol.4 , pp. 603-608
    • Tomita, N.1    Ogihara, T.2    Morishita, R.3
  • 263
    • 22144448580 scopus 로고    scopus 로고
    • Dissecting role of regulatory factors in NF-kappaB pathway with siRNA
    • Guo, J.; Fu, Y.C.; Becerra, C.R. Dissecting role of regulatory factors in NF-kappaB pathway with siRNA. Acta Pharmacol. Sin., 2005, 26, 780-788.
    • (2005) Acta Pharmacol. Sin , vol.26 , pp. 780-788
    • Guo, J.1    Fu, Y.C.2    Becerra, C.R.3
  • 264
    • 44049094771 scopus 로고    scopus 로고
    • Clinical gene therapy using recombinant adeno-associated virus vectors
    • Mueller, C.; Flotte, T.R. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther., 2008, 15, 858-863.
    • (2008) Gene Ther , vol.15 , pp. 858-863
    • Mueller, C.1    Flotte, T.R.2
  • 265
    • 68949202566 scopus 로고    scopus 로고
    • Transient transfection methods for clinical adenoassociated viral vector production
    • Wright, J.F. Transient transfection methods for clinical adenoassociated viral vector production. Hum. Gene Ther., 2009, 20, 698-706.
    • (2009) Hum. Gene Ther , vol.20 , pp. 698-706
    • Wright, J.F.1
  • 266
    • 48949098577 scopus 로고    scopus 로고
    • Gene therapy progress and prospects: Synthetic polymer-based systems
    • Schaffert, D.; Wagner, E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther., 2008, 15, 1131-1138.
    • (2008) Gene Ther , vol.15 , pp. 1131-1138
    • Schaffert, D.1    Wagner, E.2
  • 270
    • 48349105059 scopus 로고    scopus 로고
    • Novel dual inhibitory function aptamer-siRNA delivery systems for HIV-1 therapy
    • Zhou, J.; Li, H.; Li, S.; Zaia, J.; Rossi, J.J. Novel dual inhibitory function aptamer-siRNA delivery systems for HIV-1 therapy. Mol. Ther., 2008, 16, 1481-1489.
    • (2008) Mol. Ther , vol.16 , pp. 1481-1489
    • Zhou, J.1    Li, H.2    Li, S.3    Zaia, J.4    Rossi, J.J.5
  • 273
    • 70449102637 scopus 로고    scopus 로고
    • A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation
    • Stilmann, M.; Hinz, M.; Arslan, S.C.; Zimmer, A.; Schreiber, V.; Scheidereit, C. A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol. Cell, 2009, 36, 365-378.
    • (2009) Mol. Cell , vol.36 , pp. 365-378
    • Stilmann, M.1    Hinz, M.2    Arslan, S.C.3    Zimmer, A.4    Schreiber, V.5    Scheidereit, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.